Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123310) titled 'Evaluation of Artificial Intelligence System Based on Retinal Imaging in the Diagnosis and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease and Fibrosis' on April 23.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Shanghai Health and Medical Center
Condition:
metabolic dysfunction steatotic liver disease
Intervention:
AI system assists physician decision-making group:None
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-04-30
Target Sample Size: AI system assists physician decision-making group:200;Biomarker assists physici...